SCHEMBL3824657

SCHEMBL3824657

COc1cccc(-c2nc(C)oc2CN)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.51
KDM4E B2RXH2 2/20 0.46
KMT2A Q03164 2/20 0.46
ADORA2A P29274 3/20 0.45
TP53 P04637 4/20 0.44
HPGD P15428 3/20 0.44
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ALDH1A1 P00352 2/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
GLA P06280 1/20 0.44
HSD17B10 Q99714 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PIK3CG P48736 1/20 0.44
MAOB P27338 2/20 0.43
ADORA1 P30542 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3825192 0.99 DPP4 (0.50) DPP4KDM4EKMT2AADORA2ATP53
SCHEMBL3822888 0.82 DPP4 (0.49) DPP4KMT2ATP53HPGDNPC1
Hydrochloric Acid SCHEMBL3828228 0.81 DPP4 (0.48) DPP4KMT2ATP53HPGDNPC1
SCHEMBL3826037 0.80 DPP4 (0.47) DPP4KDM4EKMT2AADORA2AMAOB
Hydrochloric Acid SCHEMBL3826807 0.79 DPP4 (0.46) DPP4KDM4EKMT2AADORA2AMAOB
SCHEMBL5008393 0.79 MAPK13 (0.50) DPP4KDM4EKMT2AHPGDSMN1; SMN2
SCHEMBL3822663 0.76 MAPK13 (0.47) DPP4KDM4EKMT2AALDH1A1TDP1
SCHEMBL3824652 0.76 IKBKB (0.55) KDM4EKMT2AADORA2AHPGDSMN1; SMN2
SCHEMBL7940867 0.75 SMN1; SMN2 (0.49) KDM4EKMT2ATP53HPGDNPC1
Hydrochloric Acid SCHEMBL3821567 0.75 MAPK13 (0.46) DPP4KDM4EKMT2AALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 DPP4 23/4885KDM4E 1955/4885KMT2A 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.